- Release Date: 03/07/17 09:53
- Summary: Botanix Completes Successful Phase 1 BTX 1503 Clinical Study
- Price Sensitive: Yes
- Download Document 414.79KB
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix Completes Successful Phase 1 BTX 1503 Clinical Study
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
0.00%
!
15.0¢

Ann: Botanix Completes Successful Phase 1 BTX 1503 Clinical Study
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $294.1M |
Open | High | Low | Value | Volume |
15.0¢ | 15.3¢ | 14.8¢ | $1.563M | 10.42M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
57 | 3810077 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 2936 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
57 | 3810077 | 0.145 |
127 | 5489183 | 0.140 |
64 | 3176975 | 0.135 |
42 | 8717709 | 0.130 |
29 | 749656 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 2936 | 1 |
0.155 | 1740159 | 29 |
0.160 | 2127801 | 16 |
0.165 | 847138 | 18 |
0.170 | 1773422 | 30 |
Last trade - 16.16pm 11/08/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online